Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure

European Heart Journal

Volumn 21, Issue 16, 2000, Pages 1368-1375

  Suskin, N ^a   McKelvie, R S ^b   Burns, R J ^c   Latini, R ^d   Pericak, D ^b   Probstfield, J ^e   Rouleau, J L ^f   Sigouin, C ^b   Solymoss, C B ^f   Tsuyuki, R ^g   White, M ^f   Yusuf, S ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b HGH McMaster Clinic   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e Medical Faculty Asociates   (United States)

^f MONTREAL HEART INSTITUTE   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Glucose; Heart failure; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INCIDENCE; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PILOT PROJECTS; PROGNOSIS; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0033886497     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.2043     Document Type: Article

References (30)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA. 241:1979;2035-2038.
2. Shindler DM, Castelli WP. Diabetes Mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. JAMA. 77:1996;1017-1020.
3. Abbud ZA, Shindler DM, Wilson AC. Effect of diabetes mellitus on short and long term mortality rates of patients with acute myocardial infarction: a statewide study. Am Heart J. 130:1995;51-58.
4. Savage PJ. Cardiovascular complications of diabetes mellitus. What we know and what we need to know about their prevention. Ann Intern Med. 124:1996;123-126.
5. Shehadeh A, Regan TJ. Cardiac consequences of diabetes mellitus. Clin Cardiol. 18:1994;301-305.
6. Galderisi M, Keaven KM, Wilson PWF, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study). Am J Cardiol. 68:1991;85-89.
7. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation. 69:1984;1079-1087.
8. Gerstein HD, Yusuf S. Dysglycemia and the risk of cardiovascular disease. Lancet. 347:1996;949-950.
9. Diabetes Care. 20:1997;1183-1197.
10. Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistence, and coronary risk. J Cardiovasc Pharmacol. 20:1992;S40-S48.
11. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathetic adrenal system. N Engl J Med. 334:1996;374-381.
12. Swan JW, Anker SD, Walton C. Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure. J Am Coll Cardiol. 30:1997;527-532.
13. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone. Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation. 96:1997;4104-4113.
14. Paolissa G, De Riu S, Marrazzo G. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism. 40:1991;972-977.
15. Tsuyuki RT, Yusuf S, Rouleau JL. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta blockers in patients with congestive heart failure: Design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. Can J Cardiol. 13:1997;1166-1174.
16. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantage of a new specific activity scale. Circulation. 64:1981;1227.
17. Guyatt GH, Pugsley SO, Sullivan MJ. Effect of encouragement on walking test performance. Thorax. 39:1984;818-822.
18. Duncan MH, Singh BM, Wise PH, Carter G, Allaghband-Zadeh J. A simple measure of insulin resistance. Lancet. 346:1995;120-121.
19. Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab. 66:1988;605-610.
20. Burns RJ, Nitkin R, Weisel RD. Optimized count-based scintigraphic left ventricular volume measurement. Can J Cardiol. 1:1985;42-46.
21. N Engl J Med. 327:1992;685-691.
22. N Engl J Med. 325:1991;293-302.
23. Massie BM, Conway M, Rajagopalan B. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation. 78:1988;326-329.
24. Lopaschuk GD, Belke DD, Gamble J, Toshiyuki I, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochemica et Biophysica Acta. 1213:1994;263-276.
25. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet. 343:1994;155-158.
26. Kelly RA, Smith TW. Nitric oxide and nitrovasodilators: similarities, differences, and interactions. Am J Cardiol. 77:1996;2C-7C.
27. McKelvie RS, Benedict C, Yusuf S. Prevention of Congestive Heart Failure. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ. Evidence Based Cardiology. 1998;703-721 BMJ, London.
28. Cowie MR, Struthers AD, Wood DA. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1349-1353.
29. Benedict CR, Weiner DH, Johnstone DE. Comparative neurhormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. J Am Coll Cardiol. 22:1993;146A-53A.
30. Luchner A, Hense HW, Jougasaki M, Burnett JC Jr, Riegger GA, Schunkert H. Augmentation of natriuretic peptides by beta receptor antagonism: Evidence from a population based study. Circulation. 96:1997;I-92-I-93.